Stock screener

AGEN

Conviction 80HealthcareScan · Thu, Sep 24, 2026

Agenus Inc (AGEN) closed at $8.50 (+1.19%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 62, RS Rating 99, -2.3% from its 52-week high, +163.2% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

AGEN$8.50+1.19%
ResistanceSupportVol 14
63 bars
Vol MA14 1.01M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
AGENUS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.agenusbio.com ↗
Price8.50
Change+1.19%
Gap-0.24%
Rel volume0.92×
Avg volume923.47K
Avg $ vol7.12M
SMA 207.71
SMA 507.27
SMA 2004.44
Price vs 50+16.92%
Price vs 200+91.28%
MA stackbullish
50/200 cross—
Supertrendup · 6.94
RSI (14)62
MACD hist0.08
MACD crossbull · 2d
Stoch %K / %D85 / 87
ADX (14)32
+DI / −DI30 / 14
RSI divergence—
MACD divergence—
ATR %6.31%
ADR %6.31%
52w high8.70
52w low2.77
From 52w high-2.30%
Above 52w low+206.86%
New 52w highNo
SqueezeOff
Bollinger width29.53%
%B0.85
Donchian pos85.19%
Donchian high8.82
Donchian low6.66
AVWAP (52w high)7.61
vs AVWAP high+11.63%
AVWAP (52w low)5.90
vs AVWAP low+44.03%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d0.92×
Avg vol (14d)1.01M
Avg vol (20d)923.47K
Avg $ vol (20d)7.12M
Market cap382.67M
RS Rating99 / 99
RS 3m (vs SPY)+190.65%
RS 6m (vs SPY)+121.95%
RS line new highNo
Trend template8/8
Technical rank95.5
1 week+17.73%
1 month+1.67%
3 months+195.14%
6 months+138.76%
1 year+91.44%
YTD+163.16%
P/E-3.17
P/B-1.92
P/S3.35
P/FCF-4.96
EPS0.0000
Div yield—
ROE60.63%
ROA-69.89%
Debt/Eq-0.15
Current0.34
EV/EBITDA-38.74
Gross margin—
Net margin-105.69%
Rev growth10.37%
EPS growth4.96%
Price target26.33
Target upside209.76%
Analyst ratingBuy
Institutional38.20%
Ent. value394M
Revenue34.52M
Net income-33.73M
Gross profit—
Free cash flow-77.2M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out41.64M
Employees81
ListedFri, Feb 4, 2000
Free float35.54M
Float %92.6%
Short interest6.69M
Days to cover6.1d
Short volume54.5%
Squeeze score72 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.01 vs $0.05
Last surprise-120.0% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank95.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.84
Support6.51
Days since event—
Candle confirm—

Financials as of Sun, Sep 30, 2018 · quarterly.

Congress activity

Disclosed STOCK Act trades in AGEN

All disclosures →
No recent disclosed trades by Congress in AGEN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AGEN

InsiderSideShares
ARMEN GARO H
See Remarks · Stock Option · 2026-08-10
Grant1.97M
Corvese Brian
Director · Stock Option · 2026-08-05
Grant100K
HARRISON THOMAS L
Director · Stock Option · 2026-08-05
Grant50K
Buell Jennifer
See Remarks · Stock Option · 2026-08-05
Grant200K
Hirsch Susan B
Director · Stock Option · 2026-08-05
Grant50K
O'Day Steven J
Chief Medical Officer · Stock Option · 2026-08-05
Grant100K
Wright Timothy
Director · Stock Option · 2026-08-05
Grant50K
Wright Timothy
Director · Deferred Stock Units · 2026-07-01
Grant2.27K
HARRISON THOMAS L
Director · Common Stock · 2026-07-01
Grant8.55K
ARMEN GARO H
See Remarks · Common Stock · 2026-06-26
Grant5.36K

SEC filings

EDGAR filings in AGEN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.